Session Details

This session will highlight advances in spatial omics—including proteomics, metabolomics, and glycomics—for improving prediction, prognostication, and mechanistic understanding in breast cancer, followed by an advocate perspective and panel discussion.

Moderator

Leif W. Ellisen, Mass General Hospital/Harvard Medical School, Boston, MA

Presentation numberWS1-01

Proteomics

Sandro Santagata, Brigham and Women's Hospital, Boston, MA

Presentation numberWS1-02

Metabolomics

Ralph J DeBerardinis, UT Southwestern Medical Center, Dallas, TX

Presentation numberWS1-03

Glycomics

Daniel L. Abravanel, Dana-Farber Cancer Institute, Boston, MA

Advocate

Jane Perlmutter, Gemini Group, Ann Arbor, MI